Further evaluation of the tumor by Caris Molecular Intelligence revealed several mutations, including the NF1 variant of uncertain significance (VUS), NRAS, PBRM1, FAT1, TERT Promoter, and ATM. This evidence concerns the gene NRAS and neoplasm.